Try our Advanced Search for more refined results
6,528,530
Phenidate drug formulations having diminished abuse potential
- December 14, 2012 Mylan's Latest Focalin ANDA Brings Novartis IP Suit
- December 08, 2011 Novartis, Celgene Hit Teva Again Over ADHD Drug Patents
- June 14, 2011 Novartis, Sun Settle IP Suit Over Generic Focalin
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
- Archive of over 450,000 articles
- Database of over 2.1 million cases
- 62,000+ organization-specific pages.
- Daily and real-time news and case alerts on organizations, industries, and customized search queries.
- Significant legal events involving law firms, companies, industries, and government agencies.
- Learn more
TRY LAW360 FREE FOR SEVEN DAYS
View all the results
Already a subscriber? Click here to login